Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QazCovid-in Vaccine Phase I/II Study
NCT04530357Phase 2Completed
- Sponsor
- Research Institute for Biological Safety Problems
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of QazCovid-in in coronavirus disease 2019 (COVID-19), sponsored by Research Institute for Biological Safety Problems. Started Sep 2020; status: completed.
02
Drugs
QazCovid-in
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04530357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04530357.